is oral or injectable semaglutide better vs for Weight Loss GLP-1 Pills vs Injections (2025):

In the Retatrutide Phase 2 obesity trial, the weight-loss curve had not clearly flattened by week 48

8 Indicator #2 GLP-1 Products Dwarf Other High-Profile and Top-Selling Drugs in Revenue (FIGURE 2) Total US Revenue in First Five Years from Launch $BN The figure illustrates the total U.S

I have a concern around this shortage being only temporarily resolved, and there being sort of a yo-yo effect of the shortage coming and going over the next year

While a generic version is expected in Canada by early 2026, U.S

A 3 mg once daily dose may be appropriate for some patients, if clinically indicated

"Novo Nordisk is the only company in the U.S